Cargando…
Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2
BACKGROUND: Contemporary treatment guidelines advise statin use in all patients with diabetes for reducing coronary risk. Use of statins in patients with type 2 diabetes has not been reported from India. METHODS: We performed a multisite (n=9) registry-based study among internists (n=3), diabetologi...
Autores principales: | Gupta, Rajeev, Lodha, Sailesh, Sharma, Krishna K, Sharma, Surendra K, Gupta, Sunil, Asirvatham, Arthur J, Mahanta, Bhupendra N, Maheshwari, Anuj, Sharma, Dinesh C, Meenawat, Anand S, Khedar, Raghubir S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013346/ https://www.ncbi.nlm.nih.gov/pubmed/27648292 http://dx.doi.org/10.1136/bmjdrc-2016-000275 |
Ejemplares similares
-
Macrolevel association of COVID-19 with non-communicable disease risk factors in India
por: Gaur, Kiran, et al.
Publicado: (2021) -
Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry
por: Khedar, Raghubir Singh, et al.
Publicado: (2022) -
Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India
por: Gupta, Arvind, et al.
Publicado: (2014) -
Study of differences in presentation, risk factors and management in diabetic and nondiabetic patients with acute coronary syndrome
por: Sharma, Krishna Kumar, et al.
Publicado: (2016) -
Low quality cardiovascular care is important coronary risk factor in India
por: Gupta, Rajeev, et al.
Publicado: (2018)